Entry Detail



General Information

Database ID:exR0202116
RNA Name:hsa-miR-423-5p
RNA Type:miRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):30117095End Site(bp):30117117
External Links:hsa-miR-423-5p



Disease Information

Disease Name:Mild Cognitive Impairment
Disease Category:Other Diseases
MeSH ID:D060825
Type:Psychiatry and Psychology Category/Mental Disorders
Alias:Cognitive Dysfunction//Cognitive Dysfunctions//Dysfunction, Cognitive//Dysfunctions, Cognitive//Cognitive Impairments//Cognitive Impairment//Impairment, Cognitive//Impairments, Cognitive//Mild Cognitive Impairment//Cognitive Impairment, Mild//Cognitive Impairments, Mild//Impairment, Mild Cognitive//Impairments, Mild Cognitive//Mild Cognitive Impairments//Mild Neurocognitive Disorder//Disorder, Mild Neurocognitive//Disorders, Mild Neurocognitive//Mild Neurocognitive Disorders//Neurocognitive Disorder, Mild//Neurocognitive Disorders, Mild//Cognitive Decline//Cognitive Declines//Decline, Cognitive//Declines, Cognitive//Mental Deterioration//Deterioration, Mental//Deteriorations, Mental//Mental Deteriorations



Expression Detail

GEO ID:GSE120584
Description:Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data
Experimental Design:Disease vs Control
Case Disease Type:Alzheimer's Disease
Case Disease SubType:NA
Case Sample:Mild Cognitive Impairment
Control Sample:Normal
Number of Case:1021
Number of Control:288
Number of Samples:1309





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
DCAF7
chr17
63550477
63594279
+
PGAM1
chr10
97426191
97433444
+
MINK1
chr17
4833340
4898061
+
PSME3
chr17
42824385
42843760
+
LIMD2
chr17
63695888
63701172
-
SYVN1
chr11
65121780
65134533
-
KLC2
chr11
66257294
66267860
+
MYBL2
chr20
43667019
43716495
+
DLGAP4
chr20
36306336
36528637
+
CAPN15
chr16
527712
554636
+
MAPKBP1
chr15
41774434
41827855
+
PAK2
chr3
196739857
196832647
+
ACTN4
chr19
38647649
38731589
+
C1QTNF6
chr22
37180166
37199385
-
MAPK8IP2
chr22
50600793
50613981
+
BCORL1
chrX
129981107
130058083
+
FAM83H
chr8
143723933
143738234
-
WDR45B
chr17
82614562
82648553
-
CDCA7
chr2
173354820
173368997
+
PRR12
chr19
49591182
49626439
+
CHP1
chr15
41230839
41281887
+
TNFAIP3
chr6
137867214
137883312
+
IL2RB
chr22
37125843
37175054
-
RAB8A
chr19
16111889
16134234
+
HNRNPA2B1
chr7
26173057
26201529
-
ATN1
chr12
6924463
6942321
+
EIF5AL1
chr10
79512601
79516440
+
IGF2BP1
chr17
48997385
49056145
+
PPDPF
chr20
63520765
63522206
+
CTSD
chr11
1752755
1764573
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001472
chr5
36953719
36976504
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009133.5
chr16
29808679
29812227
+
AC016876.2
chr17
7581964
7584086
-
AC021078.1
chr5
149494314
149504670
-
AL356488.2
chr1
109100193
109100619
+
H19
chr11
1995176
2001470
-
KCNQ1OT1
chr11
2608328
2699994
-
MIR663AHG
chr20
26167817
26251546
-
MIRLET7BHG
chr22
46053869
46113928
+
NEAT1
chr11
65422774
65445540
+
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE120584
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21263
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2532
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:30820472
Title:Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data
Author:Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, Matsukuma K, Ichikawa M, Sudo H, Takizawa S, Sakurai T, Ozaki K, Ochiya T, Niida S
Journal:Commun Biol. 2019 Feb 25;2:77.
Description:we investigated potential miRNA biomarkers and constructed risk prediction models, based on a supervised principal component analysis (PCA) logistic regression method, according to the subtype of dementia